Literature DB >> 22186026

Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy.

Olga Criado1, Carmen Aguado, Javier Gayarre, Lara Duran-Trio, Ana M Garcia-Cabrero, Santiago Vernia, Beatriz San Millán, Miguel Heredia, Carlos Romá-Mateo, Silvana Mouron, Lucía Juana-López, Mercedes Domínguez, Carmen Navarro, Jose M Serratosa, Marina Sanchez, Pascual Sanz, Paola Bovolenta, Erwin Knecht, Santiago Rodriguez de Cordoba.   

Abstract

Lafora disease (LD), a fatal neurodegenerative disorder characterized by the presence of intracellular inclusions called Lafora bodies (LBs), is caused by loss-of-function mutations in laforin or malin. Previous studies suggested a role of these proteins in the regulation of glycogen biosynthesis, in glycogen dephosphorylation and in the modulation of the intracellular proteolytic systems. However, the contribution of each of these processes to LD pathogenesis is unclear. We have generated a malin-deficient (Epm2b-/-) mouse with a phenotype similar to that of LD patients. By 3-6 months of age, Epm2b-/- mice present neurological and behavioral abnormalities that correlate with a massive presence of LBs in the cortex, hippocampus and cerebellum. Sixteen-day-old Epm2b-/- mice, without detectable LBs, show an impairment of macroautophagy (hereafter called autophagy), which remains compromised in adult animals. These data demonstrate similarities between the Epm2a-/- and Epm2b-/- mice that provide further insights into LD pathogenesis. They illustrate that the dysfunction of autophagy is a consequence of the lack of laforin-malin complexes and a common feature of both mouse models of LD. Because this dysfunction precedes other pathological manifestations, we propose that decreased autophagy plays a primary role in the formation of LBs and it is critical in LD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186026     DOI: 10.1093/hmg/ddr590

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  67 in total

1.  Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.

Authors:  Erica Tiberia; Julie Turnbull; Tony Wang; Alessandra Ruggieri; Xiao-Chu Zhao; Nela Pencea; Johan Israelian; Yin Wang; Cameron A Ackerley; Peixiang Wang; Yan Liu; Berge A Minassian
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

3.  Glycogen: the missing link in neuronal autophagy?

Authors:  Akanksha Onkar; Deepashree Sheshadri; Subramaniam Ganesh
Journal:  Autophagy       Date:  2020-08-02       Impact factor: 16.016

4.  Lafora Disease Is an Inherited Metabolic Cardiomyopathy.

Authors:  María Villalba-Orero; Gentzane Sánchez-Elexpuru; Marina López-Olañeta; Oscar Campuzano; Elisabet Bello-Arroyo; Pablo García-Pavía; José M Serratosa; Ramón Brugada; Marina P Sánchez; Enrique Lara-Pezzi
Journal:  J Am Coll Cardiol       Date:  2017-06-20       Impact factor: 24.094

Review 5.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

6.  Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.

Authors:  Carla Rubio-Villena; Rosa Viana; Jose Bonet; Maria Adelaida Garcia-Gimeno; Marta Casado; Miguel Heredia; Pascual Sanz
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

7.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

8.  Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.

Authors:  Belén Mollá; Miguel Heredia; Pascual Sanz
Journal:  Mol Neurobiol       Date:  2021-01-14       Impact factor: 5.590

Review 9.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

10.  Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.

Authors:  Elisabet Augé; Carme Pelegrí; Gemma Manich; Itsaso Cabezón; Joan J Guinovart; Jordi Duran; Jordi Vilaplana
Journal:  Glia       Date:  2018-08-26       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.